Novo Nordisk A/S (FRA:NOVA)

bluebird bio Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	183,529	371,731	417,564	284,852	225,277	132,551
Market Cap Growth	-46.97%	-10.98%	46.59%	26.45%	69.96%	8.92%
Enterprise Value	193,862	369,330	414,739	283,305	222,367	129,679
Last Close Price	42.00	82.21	91.18	61.45	46.63	27.26
PE Ratio	13.09	27.45	37.19	38.16	35.07	23.41
PS Ratio	4.52	9.55	13.40	11.97	11.90	7.77
PB Ratio	9.88	19.32	29.21	25.38	23.68	15.58
P/TBV Ratio	46.95	85.58	67.43	65.10	60.74	23.12
P/FCF Ratio	17.30	37.56	37.45	31.75	34.42	21.39
P/OCF Ratio	10.43	22.92	28.58	26.86	30.45	18.99
EV/Sales Ratio	4.78	9.49	13.31	11.91	11.74	7.60
EV/EBITDA Ratio	9.24	18.78	27.97	25.98	25.93	16.48
EV/EBIT Ratio	9.86	19.69	29.53	27.87	27.92	17.83
EV/FCF Ratio	18.28	37.32	37.20	31.57	33.97	20.93
Debt / Equity Ratio	0.86	0.72	0.25	0.31	0.38	0.16
Debt / EBITDA Ratio	0.76	0.69	0.24	0.31	0.41	0.17
Debt / FCF Ratio	1.50	1.39	0.33	0.39	0.55	0.23
Asset Turnover	0.77	0.74	0.84	0.81	0.83	0.94
Inventory Turnover	1.22	1.20	1.26	1.29	1.24	1.16
Quick Ratio	0.54	0.52	0.62	0.67	0.65	0.64
Current Ratio	0.74	0.74	0.82	0.90	0.86	0.94
Return on Equity (ROE)	88.11%	80.77%	88.07%	72.00%	71.24%	69.70%
Return on Assets (ROA)	23.29%	22.41%	23.55%	21.69%	21.81%	25.01%
Return on Capital (ROIC)	47.91%	46.03%	53.89%	45.74%	43.27%	49.84%
Return on Capital Employed (ROCE)	58.00%	56.30%	72.30%	62.80%	62.30%	72.50%
Earnings Yield	7.64%	3.64%	2.69%	2.62%	2.85%	4.27%
FCF Yield	5.78%	2.66%	2.67%	3.15%	2.90%	4.67%
Dividend Yield	2.65%	1.86%	1.38%	1.36%	1.50%	2.24%
Payout Ratio	48.61%	43.71%	37.96%	45.57%	45.05%	47.75%
Buyback Yield / Dilution	0.60%	0.71%	1.10%	1.34%	1.58%	1.63%
Total Shareholder Return	3.25%	2.57%	2.48%	2.69%	3.08%	3.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.